Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin

Clicks: 278
ID: 14093
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
alexopoulos2019initialmetabolism Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Alexopoulos, A.
Journal metabolism: clinical and experimental
Year 2019
DOI
10.1016/j.metabol.2019.06.012
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.